Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$20.81
-2.1%
$22.00
$19.10
$29.55
$995.21M1.76389,948 shs394,039 shs
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$41.34
-1.5%
$40.41
$26.56
$50.85
$1.21B0.83303,225 shs316,182 shs
Outset Medical, Inc. stock logo
OM
Outset Medical
$15.04
-6.4%
$19.10
$5.85
$53.92
$284.62M2.14274,001 shs449,042 shs
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
$14.75
-1.8%
$15.81
$13.50
$25.00
$1.01B1.6147,924 shs159,304 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-2.12%-7.84%-8.53%-17.65%-13.36%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-1.48%-2.52%-6.81%+23.81%-6.98%
Outset Medical, Inc. stock logo
OM
Outset Medical
-6.35%-18.83%-26.92%+22.78%-71.76%
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
-1.80%-1.21%-3.72%-14.19%-1.40%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
2.8094 of 5 stars
3.53.00.00.02.12.50.6
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
1.7276 of 5 stars
3.40.00.00.01.42.50.6
Outset Medical, Inc. stock logo
OM
Outset Medical
1.7102 of 5 stars
3.52.00.00.02.00.80.0
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
3.9326 of 5 stars
3.51.00.04.21.94.20.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
3.00
Buy$31.0048.97% Upside
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
2.83
Moderate Buy$54.8332.64% Upside
Outset Medical, Inc. stock logo
OM
Outset Medical
3.00
Buy$29.5096.14% Upside
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
3.00
Buy$22.0049.15% Upside

Current Analyst Ratings Breakdown

Latest OM, ESTA, PLSE, and BLFS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/22/2025
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$30.00
7/16/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$58.00 ➝ $70.00
7/14/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$37.00
7/9/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$38.00 ➝ $47.00
7/7/2025
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$22.00
6/13/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$48.00
5/21/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$14.00 ➝ $21.00
5/16/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy ➝ Buy$62.00
5/15/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/14/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$48.00
5/13/2025
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$30.00 ➝ $30.00
(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$87.76M11.34$0.12 per share173.53$7.52 per share2.77
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$166.02M7.20N/AN/A$1.90 per share21.76
Outset Medical, Inc. stock logo
OM
Outset Medical
$113.69M2.34N/AN/A$7.49 per share2.01
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
$700K1,417.48N/AN/A$1.87 per share7.89
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$20.18M-$0.29N/AN/AN/A-11.81%-0.66%-0.58%8/7/2025 (Estimated)
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$84.60M-$3.10N/AN/AN/A-52.34%-196.25%-26.64%8/7/2025 (Estimated)
Outset Medical, Inc. stock logo
OM
Outset Medical
-$127.98M-$29.15N/AN/A-98.74%-143.62%-37.50%8/6/2025 (Estimated)
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
-$53.58MN/A0.00N/AN/A-68.44%-58.17%8/12/2025 (Estimated)

Latest OM, ESTA, PLSE, and BLFS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2025Q2 2025
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
-$0.26N/AN/AN/AN/AN/A
8/7/2025Q2 2025
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$0.02N/AN/AN/A$23.71 millionN/A
8/7/2025Q2 2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$0.54N/AN/AN/A$50.80 millionN/A
8/6/2025Q2 2025
Outset Medical, Inc. stock logo
OM
Outset Medical
-$1.76N/AN/AN/A$29.40 millionN/A
5/8/2025Q1 2025
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$0.03$0.04+$0.07-$0.01$22.22 million$23.94 million
5/8/2025Q1 2025
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
N/A-$0.25N/A-$0.25N/AN/A
5/7/2025Q1 2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$0.83-$0.70+$0.13-$0.70$41.15 million$41.38 million
5/7/2025Q1 2025
Outset Medical, Inc. stock logo
OM
Outset Medical
-$0.97-$3.66-$2.69-$3.66$27.81 million$29.75 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
N/AN/AN/AN/AN/A
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
N/AN/AN/AN/AN/A
Outset Medical, Inc. stock logo
OM
Outset Medical
N/AN/AN/AN/AN/A
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
0.01
4.73
3.74
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
5.72
3.36
2.05
Outset Medical, Inc. stock logo
OM
Outset Medical
0.57
8.37
6.74
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
N/A
15.58
15.58

Institutional Ownership

CompanyInstitutional Ownership
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
93.24%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
72.91%
Outset Medical, Inc. stock logo
OM
Outset Medical
N/A
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
76.95%

Insider Ownership

CompanyInsider Ownership
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
2.20%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
11.09%
Outset Medical, Inc. stock logo
OM
Outset Medical
2.40%
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
71.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
44047.84 million46.78 millionOptionable
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
1,01828.92 million25.71 millionOptionable
Outset Medical, Inc. stock logo
OM
Outset Medical
52017.72 million17.30 millionNot Optionable
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
14067.27 million19.17 millionOptionable

Recent News About These Companies

Pulse Biosciences: Some Key Questions Remain Unanswered

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
BioLife Solutions stock logo

BioLife Solutions NASDAQ:BLFS

$20.81 -0.45 (-2.12%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$20.80 0.00 (-0.02%)
As of 08/1/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Establishment Labs stock logo

Establishment Labs NASDAQ:ESTA

$41.34 -0.62 (-1.48%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$41.01 -0.33 (-0.80%)
As of 08/1/2025 06:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Outset Medical stock logo

Outset Medical NASDAQ:OM

$15.04 -1.02 (-6.35%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$15.48 +0.44 (+2.93%)
As of 08/1/2025 07:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Pulse Biosciences stock logo

Pulse Biosciences NASDAQ:PLSE

$14.75 -0.27 (-1.80%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$14.73 -0.02 (-0.14%)
As of 08/1/2025 06:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.